ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Aledade Share Class Level Preferred Share Class Type Seri

Aledade Share Class Level Preferred Share Class Type Seri (LEDAPAX)

0.00
0.00
(0.00%)
Cerrado 09 Julio 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Aledade Share Class Level Preferred Share Class Type Seri (LEDAPAX) Cotización

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
-
( - )
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

LEDAPAX Últimas noticias

No hay noticias para mostrar aún.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

LEDAPAX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aledade Share Class Level Preferred Share Class Type Seri?
El precio actual de las acciones de Aledade Share Class Level Preferred Share Class Type Seri es US$ 0.00
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aledade Share Class Level Preferred Share Class Type Seri?
Aledade Share Class Level Preferred Share Class Type Seri ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

LEDAPAX Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
srinsocal srinsocal 2 minutos hace
Think Big, "100000 in stock"

https://shop.painkiller.care/products/painkiller%E2%84%A2-actipatch%C2%AE-pallet-1-200-units?pr_prod_strat=e5_desc&pr_rec_id=f01c51e9e&pr_rec_pid=8084178141253&pr_ref_pid=8043131961413&pr_seq=uniform

https://shop.painkiller.care/products/pai
BIEL
watcher777 watcher777 4 minutos hace
That's hanging around is to see what actually happens in this thing. I don't have the balls to put money in this and nor do I think it's going to do as well as other things can. However, I've been In and out of this dumpster fire for just over 13 years and there's nothing that can convince me this i
LQMT
GoodGuyBill GoodGuyBill 5 minutos hace
I get what you’re saying — yes, MHRA has been consistent for weeks in signaling that NWBO’s silence is self-chosen. But that actually reinforces the point I’m making, not the one you’re making. The fact that MHRA has repeatedly confirmed active review, acknowledged clinical impact, and
redir
NWBO
88TH MAN 88TH MAN 7 minutos hace
Holding all my shares. BULLISH!!!
UMAV
88TH MAN 88TH MAN 8 minutos hace
Holding all my shares. BULLISH!!!
USMJ
DJknows DJknows 8 minutos hace
I was supposed to quit for the night with the last post but thought I'd check out Mr. Taylor's LinkedIn and found the following:

https://www.linkedin.com/in/rodolfo-taylor-07b32791/recent-activity/all/

Rodolfo Taylor
Automotive Professional Consultant. Specializi
LWLG
ghostandgurgi ghostandgurgi 9 minutos hace
Even 1-100 split only gets this to $3 and they need $4 to uplist, so not sure how they plan to get there.
FDCTD
johnydollar johnydollar 9 minutos hace
Sometimes i wonder how old some people are...........

Online........

Am sure some do have snot running down their nose.......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆
DBMM
Hey_Its_That_Guy Hey_Its_That_Guy 11 minutos hace
Because you touch yourself at night
FNMA
biotech_researcher biotech_researcher 14 minutos hace
Well, most of have reached the 3.5 year point from our last shot, so we can be confident that the vaccine has cleared. What’s the point of this article?
PFE
johnydollar johnydollar 14 minutos hace
For a minute there i thought about lucky Gilmore..........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
Jetmek_03052 Jetmek_03052 15 minutos hace
LOLOLOLOL!
DBMM
88TH MAN 88TH MAN 16 minutos hace
Buy, buy, buy... Hold, hold, hold... Profit, profit, profit. BULLISH!!!
XERI
Porch Honkey Porch Honkey 16 minutos hace
Nonsense, lol. Craig Marshak holds the Wertheim trademark name and sits on your company's board as a private director of that company, per se, lmao!
GTCH
samson8 samson8 17 minutos hace
500 million more shares added today
INKW
88TH MAN 88TH MAN 18 minutos hace
Charles Schwab shows $0.10. The chart on E*Trade shows $0.10. I am convinced $0.10 is the true price. I had an order to Sell at $0.10. At this point, I will not sell for less than $0.10. BULLISH!!!
FBEC
SkiMan85 SkiMan85 19 minutos hace
I think GetRch$lwly laid out a reasonable “everything goes perfectly” scenario, but I still think it’s probably too optimistic.

NAMSA absolutely improves the odds of getting the IDE right the first time, but it doesn’t eliminate FDA review timelines or potential questions. They still
UEEC
DrivenByPain DrivenByPain 20 minutos hace
🤑SNTX🤑 You All Ready To See A Million + In Your Accounts $🤑$🤑$🤑$🤑$🤑$🤑$🤑Elon Be Liking Mr Leal !
SNTX
KeepItRealistic KeepItRealistic 23 minutos hace
$OSRH what is there not to like 💎 
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga
CVR OSRH
KeepItRealistic KeepItRealistic 23 minutos hace
$OSRH what is there not to like 💎 
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga
CVR OSRH
Kentucky123 Kentucky123 24 minutos hace
I know most do not follow charts and think they are useless for low cap bio. They have been right for the last five years. In order for that to change I believe we need to see volume of 10 million shares on big news. Here is the chart.
https://schrts.co/mHVrctPW
AVXL
hankmanhub hankmanhub 25 minutos hace
• “…recognizing the impact this medicine could potentially have.”
This could be true of every single treatment that is up for approval, as a new treatment not yet available prior to approval,
NWBO
Guido2 Guido2 32 minutos hace
https://x.com/GuidoPerei/status/2075395630298804549?s=20
FNMA
DJknows DJknows 33 minutos hace
One new comment on today's The Luminary Live program from Rodolfo Taylor:

https://www.linkedin.com/in/robertblum/recent-activity/comments/

Rodolfo Taylor
Automotive Professional Consultant. Specializing in Next-Gen Mobility, Advancing the Transition from Copper t
LWLG

Su Consulta Reciente

Delayed Upgrade Clock